oral, first-in-class CHIT1/AMCase chitinase inh.
for sarcoidosis/lung fibrosis, Ph. Ib complete
from opt. of literature molecule
J. Med. Chem., Oct. 20, 2020
OncoArendi Therapeutics SA, Warsaw, PL
OATD-01
1 min read
OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)
Search By Structure
- BAY 1214784
- BAY 1217224
- CC-90011
- LEO 39652
- OATD-01
- AG-636
- “compound 46”
- “compound 25”
- “lipid 10a”
- BAY-6672
- “compound 27”
- “EST73502”
- CG428
- “compound 34”
Molecules of the Month
2023
2022
2021
2020